Mitigating Risk in Pathogen Safety- An Interview with Jürgen Blusch
Jürgen Blusch, Head of Cell Substrate Analytics at Novartis speaks to Pharma IQ on the topics of mitigating risk in pathogen safety, new technologies and techniques such as nucleic acid based techniques for safety testing. He also spoke about what is limiting the uptake of these promising techniques.
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.